HOME >> MEDICINE >> NEWS
Facial transplants are justified, say experts

With news of the world's first facial transplant hitting the headlines, experts in this week's BMJ debate whether the benefit of this procedure to someone with severe facial deformity outweighs the risk of long term suppression of the immune system.

One of the main areas of concern has been the risk to patients from the side effects of long term immunosuppression, say the authors. However, a patient having a facial transplant would probably require a similar level of immunosuppression to patient having a kidney transplant.

Given that one of the main justifications for kidney transplantation is improvement in quality of life, the same argument should apply to facial transplant, they write.

Concern over psychological effects is also misplaced, they say. They argue that a psychological change is not necessarily a psychological problem, and believe that the psychological impact of facial transplant can be anticipated, planned for and managed.

In terms of public fears over altered identity, the authors explain that modelling of the change in appearance, using laser scanning and photography, shows that this does not occur after facial transplantation. "Indeed, preoccupation with altered identity risks becoming too much of a distraction from the important issue of managing immunosuppression," they warn.

Although research has made the concept of facial transplant a reality, concerns about long term immunosuppression do remain. "But, instead of considering why facial transplantation cannot be justified, we may find it hard to justify why it should not be done," they conclude.


'"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-020-738-36529
BMJ-British Medical Journal
8-Dec-2005


Page: 1

Related medicine news :

1. Facial resurfacing treats precancerous skin lesions, may help prevent skin cancer
2. Facial trauma may cause significant social and behavioral problems
3. Thymus transplants gives hope to babies with fatal immune disease
4. Outcomes for patients with hepatitis B who need liver transplants
5. Women given liver transplants outlive male recipients by around 4 years
6. How tumors respond to treatment prior to liver transplants may be useful in selecting recipients
7. National trial gives unprecedented support for steroid withdrawal in kidney transplants
8. Organ transplants just as successful in those with mental retardation
9. Liver transplants can be successful in HIV patients with Hepatitis B
10. Stem cell transplants improve recovery in animal models for stroke, cerebral palsy
11. Despite medical advances, children receiving liver transplants wait longer than a decade ago

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Facial transplants are justified say experts

(Date:9/2/2015)... ... , ... Every year at this time, students prepare to go back to ... face the academic workload confronting them. They just don’t have the skills needed to ... teach students how to study. , “Bankers bank. Salesmen sell. Teachers teach. The job ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... announces Hand Free Pocket Cop, a safety invention that protects people from crime ... worth $31 billion," says Scott Cooper, CEO and Creative Director of World Patent ...
(Date:9/2/2015)... ... , ... Ovarian cancer continues to be the deadliest of all gynecologic cancers. ... her lifetime is approximately 1 in 75. This year it is estimated that approximately ... , There is no test to detect ovarian cancer. A Pap test does ...
(Date:9/2/2015)... , ... September 02, 2015 , ... ... the pioneer in marine cosmetics introduces PIONNIÈRE XMF Perfection Youth Rich Cream ... cream combines breakthrough biotechnological anti-aging power with a lipid-replenishing marine oil for intense ...
(Date:9/2/2015)... ... September 02, 2015 , ... Canopy Partners, a North Carolina ... Inc. 5000 List, an independent ranking of the fastest- growing private companies ... this achievement puts Canopy in rarefied company. Over the years, this elite group ...
Breaking Medicine News(10 mins):Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 2Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 3Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 2Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 3Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 4Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 5Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 6Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 7Health News:National Ovarian Cancer Coalition's DFW Chapter Features First Annual Teal Lights Display This Friday, September 4th, "National Wear Teal Day" 2Health News:National Ovarian Cancer Coalition's DFW Chapter Features First Annual Teal Lights Display This Friday, September 4th, "National Wear Teal Day" 3Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 2Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 3Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 4Health News:Canopy Partners Named to 2015 Inc. 5000 Fastest Growing Companies List 2
(Date:9/2/2015)... -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and ... into a definitive agreement under which Valeant will acquire ... SURG ) for $6.50 per share in cash. In ... receive additional cash payments of up to $1.00 per ... closing.  The transaction is expected to close in the ...
(Date:9/2/2015)... 2015 Tumultuous market conditions – including changes ... M&A activity – have led more than half of ... sales reps. This marks the first time that the ... halfway point, according to the spring 2015 AccessMonitor™ ... ZS . AccessMonitor™ aggregates sales-call ...
(Date:9/2/2015)... JUNCTION, N.J. , Sept. 2, 2015 ... immunotherapy leader commercializing its CytoSorb ® blood purification ... around the world, announced that CEO Dr. Phillip ... & Renshaw Annual Global Investment Conference (sponsored by ... 8-10 th in New York City.  ...
Breaking Medicine Technology:Valeant Pharmaceuticals To Acquire Synergetics USA 2Valeant Pharmaceuticals To Acquire Synergetics USA 3Valeant Pharmaceuticals To Acquire Synergetics USA 4Valeant Pharmaceuticals To Acquire Synergetics USA 5Crossing the threshold: More than half of physicians restrict access to sales reps 2Crossing the threshold: More than half of physicians restrict access to sales reps 3Crossing the threshold: More than half of physicians restrict access to sales reps 4Crossing the threshold: More than half of physicians restrict access to sales reps 5CytoSorbents to Present at the 2015 Rodman & Renshaw Annual Global Investment Conference 2CytoSorbents to Present at the 2015 Rodman & Renshaw Annual Global Investment Conference 3CytoSorbents to Present at the 2015 Rodman & Renshaw Annual Global Investment Conference 4
Cached News: